Placeholder. A fresh dog food brand has shifted its entire R&D philosophy from asking 'does this meet minimum nutritional standards' to actually measuring dogs' inflammatory and lipid biomarkers through clinical trials — applying the same precision-nutrition science increasingly used in human longevity research directly to commercial dog food.
What we've found so far: Ollie's R&D team explicitly measures inflammatory markers (C-reactive protein, TNF-alpha) and lipid profiles via clinical feeding trials rather than assuming a generic formula works for all dogs — a genuine shift from 'meets minimums' to 'optimizes biomarkers.'
Open research: Interview Ollie's R&D lead directly on what specific biomarker improvements they've documented and over what timeframe; compare their clinical trial rigor to standard AAFCO feeding-trial requirements.